Alexandria, VA--November 4, 1999-- Researchers have found that non-steroidal anti-inflammatory agents like aspirin and ibuprofen are strongly associated with the presence of GERD or Gastroesophageal Reflux Disease.
GERD is an involuntary reflux recently linked to throat cancer. Using Medicaid patients in Georgia as their sample, researchers also compared the incidence of GERD among different racial groups. They found that white female Medicaid patients are 57% more likely to experience GERD than their black counterparts. This new data is a red flag for patients who rely heavily on aspirin or ibuprofen for pain relief.
This topic and others will be presented at the American Association of Pharmaceutical Scientists (AAPS) Annual Meeting "Quest for the Magic Bullet: An Astounding Century." More than seven thousand pharmaceutical scientists from around the world will gather at the New Orleans meeting, November 14-18, to share the latest scientific research.
AAPS is a professional, scientific society of more than 9,000 members employed in academia, industry, government and other research institutes worldwide. Founded in 1986, AAPS aims to advance science through the open exchange of scientific knowledge, serve as an information resource, and contribute to human health through pharmaceutical research and development. For more information about AAPS, visit AAPS Online at http://www.aaps.org.
* * *
Editor's Note: For more information on the above research or to set up interviews with researchers, please contact Hannah Elinson ([email protected]) or Marie Bertot ([email protected]) at 305-573-9955. Abstracts of data can be previewed in a fully-searchable database on AAPS Online (www.aaps.org) or for complete up-to-date meeting information, please check out the AAPS Newsroom at http://www.aaps.org/sciaffairs/news.html.
RSS